Semaglutide Once-Weekly Bests Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Insulin Glargine as Add-on to Metformin (With or Without Sulfonylureas) in Insulin-Naive Patients With Type 2 Diabetes (SUSTAIN 4): A Randomised, Open-Label, Parallel-Group, Multicentre, Multinational, Phase 3a Trial
Lancet Diabetes Endocrinol 2017 Mar 23;[EPub Ahead of Print], VR Aroda, SC Bain, B Cariou, M Piletič, L Rose, M Axelsen, E Rowe, JH DeVriesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.